title: Pulmonary aspergillosis in solid organ transplant patients: a report from Iran.
abstract: BACKGROUND
  Aspergillosis is one of the most important opportunistic infections after organ transplantation. Early diagnosis and initiation of appropriate antifungal therapy are key factors for better prognosis.
  
  
  METHODS
  We reviewed the medical records of patients with solid organ transplantation with evidence of Aspergillus infections from December 2001 to January 2008, evaluating patient demographics, time of onset after transplantation, risk factors, radiologic appearance, diagnostic criteria, antifungal therapy, and outcome.
  
  
  RESULTS
  We observed aspergillosis in 8 lung, 3 kidney, and 1 heart recipient, with overall mean age of 40.6 years. Seven cases of Aspergillus tracheobronchitis were diagnosed in lung transplant recipients, all of them in the first 6 months after transplantation. All patients responded to antifungal therapy and bronchoscopic debridement. We observed 5 cases of invasive pulmonary aspergillosis. Three patients survived in response to antifungal treatment. The two patients who died were treated with a combination of itraconazole and amphotericin B, whereas all cured patients had been treated with voriconazole alone or in combination with caspofungin.
  
  
  CONCLUSIONS
  It seems that the prognosis of aspergillosis in solid organ recipients is improving with new treatment regimens, particularly if they are used in early stages of infection.
authors.affiliation: Transplant Research Center, Massih Daneshvari Hospital, Darabad-Niavaran, Tehran, Iran.
authors.forename: M
authors.initials: M
authors.lastname: Marjani
authors.forename: P
authors.initials: P
authors.lastname: Tabarsi
authors.forename: K
authors.initials: K
authors.lastname: Najafizadeh
authors.forename: F
authors.initials: F
authors.lastname: Rashid Farokhi
authors.forename: B
authors.initials: B
authors.lastname: Sharifkashani
authors.forename: S
authors.initials: S
authors.lastname: Motahari
authors.forename: A
authors.initials: A
authors.lastname: Abbasi
authors.forename: M R
authors.initials: MR
authors.lastname: Masjedi
authors.forename: D
authors.initials: D
authors.lastname: Mansouri
mesh_terms: D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D003646:Debridement / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007492:Iran; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000401:mortality; D008175:Lung Neoplasms / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000382:microbiology; D055732:Pulmonary Aspergillosis / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery; D012189:Retrospective Studies; D016019:Survival Analysis; D017741:Survivors; D055815:Young Adult
chemical_list: D000935:Antifungal Agents